Immuneering (IMRX) Net Income (2020 - 2026)
Immuneering's Net Income was -$17.92 million in Q2 2026, compared with -$14.43 million a year earlier.
Powered by 
Analysis
Immuneering (IMRX) Net Income (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Immuneering's Net Income was -$58.75 million through Jun 30, 2026; for FY2025, it came in at -$56.34 million.
- In earlier years, Net Income was -$61.48 million in FY2024, -$54.81 million in FY2023, -$50.51 million in FY2022 and -$33.54 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Net Income since Q4 2024.
- Per Business Quant data, IMRX's Net Income in the three quarters before Q2 2026 was -$13.97 million (Q1 2026), -$11.89 million (Q4 2025) and -$14.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Immuneering | 241.64 Mn | -465.34 Mn | - | -17.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.27 Mn |
| Mar 31, 2026 | -13.46 Mn |
| Dec 31, 2025 | -11.58 Mn |
| Sep 30, 2025 | -14.96 Mn |
| Jun 30, 2025 | -14.43 Mn |
| Mar 31, 2025 | -15.05 Mn |
| Dec 31, 2024 | -18.05 Mn |
| Sep 30, 2024 | -14.60 Mn |
| Jun 30, 2024 | -14.08 Mn |
| Mar 31, 2024 | -14.31 Mn |
| Dec 31, 2023 | -15.08 Mn |
| Sep 30, 2023 | -12.60 Mn |
| Jun 30, 2023 | -12.19 Mn |
| Mar 31, 2023 | -13.60 Mn |
| Dec 31, 2022 | -13.25 Mn |
| Sep 30, 2022 | -12.84 Mn |
| Jun 30, 2022 | -11.53 Mn |
| Mar 31, 2022 | -12.90 Mn |
| Dec 31, 2021 | -10.78 Mn |
| Sep 30, 2021 | -8.53 Mn |
API Access
Immuneering Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=IMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "IMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=IMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();